Kalorama Information offers relevant market research in the areas of molecular point-of-care (POC) diagnostics, traditional POC diagnostics, and physician office laboratory (POL) test markets. Market information in this post was drawn from the associated reports.
In a recent article of the New England Journal of Medicine (NEJM), health and medical experts convincingly argued for the establishment of an Essential Diagnostics List (EDL) modeled on the existing Essential Medicines List (EML). Effective use of essential medicines, including stewardship of distributed antibiotics, would be encouraged through the equal availability of diagnostics. In this post, Kalorama Information identified several core EDL test categories outlined by the NEJM article’s authors that are represented by currently marketed physician office laboratory (POL) and point-of-care (POC) diagnostics. While the potential to address future EDL-driven markets through existing IVD products exists, significant cost improvements will be necessary.